Kazia Therapeutics (KZIA) Exchange Rate Effect (2016 - 2022)
Kazia Therapeutics' (KZIA) quarterly Exchange Rate Effect came in at $95615.7 in Q4 2022, down 78.11% YoY from $436897.2 in Q4 2021, and down 78.11% on a QoQ basis from $436897.2 in Q4 2021.
Kazia Therapeutics (KZIA) Exchange Rate Effect (2016 - 2022) Analysis & Trends
Kazia Therapeutics (KZIA) has 4 years of Exchange Rate Effect data on file, last reported at $95615.7 in Q4 2022.
- Quarterly Exchange Rate Effect fell 78.11% year-over-year to $95615.7 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$773467.4 (down 3.81% YoY) and the FY2025 annual result came in at -$10246.9, down 229.57% from the prior year.
- Exchange Rate Effect fell to $95615.7 in Q4 2022, from $436897.2 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $436897.2 in Q4 2021 to a low of -$1.3 million in Q4 2020.
- A 3-year average of -$248987.4 and a median of $95615.7 in 2022 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2021 — Exchange Rate Effect jumped 134.15% — and 2022, when it slumped 78.11%.
- Tracing KZIA's Exchange Rate Effect over 3 years: stood at -$1.3 million in 2020, then jumped by 134.15% to $436897.2 in 2021, then tumbled by 78.11% to $95615.7 in 2022.
- The last three Exchange Rate Effect figures came in at $95615.7 (Q4 2022), $436897.2 (Q4 2021), and -$1.3 million (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Kazia Therapeutics | 4.22 Bn | 4.22 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 95,615.73 |
| Dec 31, 2022 | 95,615.73 |
| Dec 31, 2021 | 436,897.19 |
| Dec 31, 2021 | 436,897.19 |
| Dec 31, 2020 | -1.28 Mn |
| Dec 31, 2020 | -1.28 Mn |
| Dec 31, 2016 | -26,505.35 |
| Dec 31, 2016 | -26,505.35 |